Clinical Trials Browser

OTHER × Neoplasms × Hydroxymethylglutaryl-CoA Reductase Inhibitors × Clear all

NCT05976893 2023-08-04

Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer

Phase 4 Unknown

Neoplasms, Atherosclerosis

NCT03186404 2022-02-08

SPARE-HF

Phase 2 Unknown

Heart Failure, Neoplasms, Cardiotoxicity